Key result
MarrowMet reveals asymmetric bone marrow activation across CVD models, with sternal uptake increasing ~80% post-MI.
Why the study?
The spatial heterogeneity of bone marrow activation in inflammatory cardiovascular diseases and its systemic representation remain unclear.
Does whole-body ex vivo 18F-FDG profiling (MarrowMet) reveal spatially asymmetric bone marrow metabolic and immune activation across different cardiovascular and inflammatory pathologies in mice?
Does whole-body ex vivo 18F-FDG profiling (MarrowMet) reveal spatially asymmetric bone marrow metabolic and immune activation across different cardiovascular and inflammatory pathologies in mice?
Answers are grounded in this paper and cite their sources.
This preclinical study demonstrates that bone marrow immune and metabolic responses to cardiovascular diseases are spatially heterogeneous—with the sternum and skull exhibiting distinct activation patterns compared to the femur—challenging the standard practice of relying solely on femoral marrow as representative of systemic hematopoietic activity.
F-FDG bone marrow uptake strongly correlated with inflammatory activity, we applied MarrowMet to map site-specific activation patterns across diverse cardiovascular pathologies, including mouse models of inflammatory atherosclerosis, acute ischemic events, acute respiratory distress syndrome, metabolic syndrome, and aging. MarrowMet guided the selection of bone marrow regions of interest for in-depth mass cytometric analyses, with the skull and sternum emerging as critical sites exhibiting distinct immune and metabolic profiles in cardiovascular disease. These results challenge the prevailing view that femoral marrow represents systemic activity. Together, this work lays a foundation for whole-body exploration of bone marrow heterogeneity, yielding critical insights into cardiovascular disease and associated inflammatory responses, and MarrowMet can be readily adopted to profile other immune mechanisms in a variety of pathologies, including cancer and autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Deckers et al. (2026) studied Inflammatory cardiovascular disease (mouse models of systemic inflammation, aging, metabolic syndrome, atherosclerosis, myocardial infarction, stroke, and acute respiratory distress syndrome). MarrowMet (18F-FDG ex vivo gamma-counting and CyTOF profiling across experimental cardiovascular/inflammatory insults) vs. Control diet, PBS, or naive/sham control mice was evaluated on Weight-corrected 18F-FDG uptake (%ID/g) and immune/metabolic profiles across 11 spatially distinct bone marrow sites (p=0.014). MarrowMet profiling in mice revealed asymmetric bone marrow activation in CVD, with sternal 18F-FDG uptake dominating in atherosclerosis and increasing 80% post-MI but decreasing 30% post-stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: